Best Practices - Why commercializing a technology is really, really hard to do
SUCCESS AND FAILURE IN NEW VENTURE CREATIONThere is often a significant disconnect between those who conceptualize and generate technology and those that later commercialize the technology. This disconnect is in large part due to a mismatch in culture and resources as technology transitions from research into product development and later manufacturing. Jesko will review the critical elements that can position an early stage venture for success – and highlight those elements which are likely to lead to failure. Jesko's talk will be followed by an informal discussion and exchange of ideas.
SPEAKER Jesko von Windheim, CEO, Nextreme Thermal Solutions Inc. |  |
DATE | TIME | LOCATION
July 12, 200612:00PM - 2:00PM
MaRS Collaboration Centre
101 College St, Toronto
ABOUT THE SPEAKER
Jesko von Windheim, Chief Executive Officer Nextreme Thermal Solutions, Inc.
Jesko von Windheim is CEO at Nextreme Thermal Solutions, Inc. He helped spin Nextreme out of RTI International, where he was Entrepreneur in Residence and VP of Commercialization. Prior to joining RTI, Jesko was involved with numerous spin-offs from MCNC, Corp. (also a research organization), the most recent of which was Cronos Integrated Microsystems which sold to JDS Uniphase. At Cronos Jesko was VP of Marketing and Business development and he later ran the business unit as General Manager for JDS Uniphase. Jesko holds a bachelor's degree in chemistry and physics, a master's degree and a Ph.D. in physical chemistry, and an MBA from the Kenan-Flagler business school.
Jesko is a Canadian who has been involved in the commercialization of a number of technologies out of US research institutions. He is a keen student of the process of commercialization and has been developing a more systematic approach to moving technologies to market. He lectures frequently on related topics, and has been actively involved in transitioning research platforms out of the lab.
UPCOMING EVENTS
PAST EVENTS
- October 9, 2008
Best Practices: Is Your Business Model Creative? - June 3, 2008
MaRS Best Practices Series - Good Laboratory Practices - May 13, 2008
MaRS Best Practices Series - From bench top to IND - April 24, 2008
MaRS Best Practices Series - IP Strategies for Medical Devices - April 7, 2008
MaRS Best Practices Series - Doing Business with the National Institutes of Health (NIH): Opportunities for industry - March 29, 2008
MaRS Best Practices Series - How to Draft a Patent Application - March 20, 2008
MaRS Best Practices Series - IP Strategies for Therapeutics - February 28, 2008
MaRS Best Practices Series - IP Strategies for Diagnostics - February 23, 2008
MaRS Best Practices Series - How to Draft a Patent Application - December 12, 2007
MaRS Best Practices Series - Focus on CNS Pharma deals: How to pull in the money - May 23, 2007
MaRS Best Practices Series - Pre-Clinical development workshop - MaRS Best Practices Series - Asymmetric Communications: Building Momentum through Non-Traditional Marketing
- April 11, 2007
MaRS Best Practices Series - Intellectual Property and Valuation of Emerging Medical Therapeutics - November 21, 2006
MaRS Best Practices Series - Business, Science, Technology and You: Financing R&D through Canada’s SR&ED Program - November 9, 2006
MaRS Best Practices Series - Introduction to Systems Biology - September 14, 2006
MaRS Best Practices Series - From Bench to Headline: Translating science for the media - September 8, 2006
MaRS Besst Practices Series - The Power of Pictonics: Using visualizations to tell your technology story - July 12, 2006
MaRS Best Practices Series - Why commercializing a technology is really, really hard to do - May 17, 2006
MaRS Best Practices Series - So what? Who cares? Why you? - April 5, 2006
MaRS Best Practices Series - The move toward drug development - February 11, 2006
MaRS Best Practices Series - How To Draft a Patent Application - February 9, 2006
MaRS Best Practices Series - New Technologies for Accelerating Drug Development
